Gene Query: COL5A1

Dataset Description Geneva Score
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 211.8
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 189.43
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 159.78
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 147.73
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 147.73
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 146.5
hnRNP C is a key regulator of protein synthesis in mitosis 135.84
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 135.74
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 133.56
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 132.97
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 132.97
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 131.84
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 124.48
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 119.31
Global expression profiles in cardiac progenitor cells generated by ISX-9 119.31
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 114.46
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 103.44
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 101.99
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 101.98
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 101.47
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 100.11
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 97.44
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 96.89
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 96.69
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 95.63
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 88.07
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 88.07
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 87.45
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 86.19
Nrf2 regulated genes in A549 cells 81.55
Identification of Nrf2 regulated genes by RNA sequencing 81.55
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 80.24
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 79.63
RNA expression following TMPRSS11B overexpression or depletion 76.9
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 76.34
Nutritional control of protein translation 75.53
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 74.83
RNA-seq analysis of RALD iPSCs after in vitro differentiation 73.71
RNA-seq of MDA-MB-231 cells with TET1 knockout 67.71
Regionally specified human pluripotent stem cell-derived astrocytes 65.08
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 64.17
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 63.95
Global analyses of the effect of different cellular contexts on microRNA targeting 63.95
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 62.45
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 62.3
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 62.06
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 60.56
Cajal bodies are linked to genome conformation [RNA-Seq] 59.72
Cajal bodies are linked to genome conformation 59.72
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 58.03
Gene expression analysis of immortalized human liver progenitor-like cells in culture 56.79
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 56.16
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 55.3
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 53.95
Rorc disruption in human FG pancreatic cancer cells 53.92
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 53.72
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 52.62
Silencing p300 in MCF7 cells to study expression and alternative splicing 52.6
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 52.28
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 52.14
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 52.12
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 51.7
IDH3a KO RNA-seq 51.45
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 50.49
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 50.49
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 50.1
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 49.94
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 49.93
Maturation of human iNSCs 49.52
STRIPAK directs PP2A activity to promote oncogenic transformation 48.24
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 48.21
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 47.4
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 47.24
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 46.69
A549 cells and MSR-A549 cells 46.69
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 46.66
RNA-seq analysis to identify the genes regulated by p53-SET interplay 46.53
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 46.34
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 46.28
RNA-seq in HepG2 and IMR90 cells 45.91
Evolution of a transcriptional regulator from a transmembrane nucleoporin 45.91
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 45.87
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 45.79
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 45.77
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 45.64
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 45.18
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 45.13
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 45.13
SUV420H2 knockdown in PANC-1 44.67
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 44.41
MEIS1 regulates hematopoiesis in hPSCs 43.95
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 43.88
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 43.88
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 43.61
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 43.61
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 43.34
Argonaute proteins couple chromatin silencing to alternative splicing 43.34
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 43.23
CHCHD10 gene KO effect in iPSC drived motor neurons 43.14
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 42.62
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 42.24
RNA-seq of MCF10A cells and CAF 42.15
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 41.92
Lineage specific differentiation is influenced by state of human pluripotency 41.92
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 41.86
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 41.57
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 41.43
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 41.43
The Genomic Landscape of Atypical Fibroxanthoma 40.95
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 40.71
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 40.67
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 40.39
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 40.39
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 40.29
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 39.86
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 39.86
Functional role of SLIT2 and ROBO1 in trophoblasts 39.53
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 38.72
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 38.63
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 38.52
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 38.52
RNA sequencing of human mammary epithelial cells 38.04
H1609088 Human RNA-Sequencing 37.87
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 37.64
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 37.28
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 37.28
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 36.85
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 36.78
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 36.17
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 35.91
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 35.91
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 35.85
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 35.85
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 35.8
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 35.64
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 35.64
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 35.64
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 35.63
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 35.63
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 35.43
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 35.37
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 35.3
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 35.3
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 35.02
RNA-Seq from early time points in the kidney differentiation protocol 34.95
RNA Seq of HMVEC under hypoxia 34.19
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 34.19
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 33.97
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 33.81
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 33.78
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 33.5
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 33.35
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 33.3
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 33.11
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 33.11
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 33.04
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 32.99
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 32.96
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 32.96
DJ-1 is dispensable for human stem cell homeostasis 32.88
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 32.75
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 32.74
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 32.69
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 32.69
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 32.66
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 32.61
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 32.51
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 32.5
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 32.48
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 32.47
RNA-seq of cells with TET1 knockout 32.33
RNA-sequencing of human liver tissue 32.26
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 32.22
A prostate cancer chromatin interaction map 32.14
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 32.02
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 32.0
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 31.53
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 31.48
Transcriptome analyses of human pancreatic islets and pseudoislets 31.4
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 31.36
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 31.21
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 31.15
iPSC derived motor neuron cultures from C9ORF72 carriers 30.9
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 30.86
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 30.52
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 30.15
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 30.15
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 30.05
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 29.82
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 29.57
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 29.47
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 29.42
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 29.33
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 29.31
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 29.25
Toxoplasma gondii infection of human retinal pigment epithelial cells 29.16
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 28.95
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 28.95
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 28.82
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 28.74
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 28.69
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 28.66
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 28.55
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 28.49
Cerebellar differentiation in Ataxia-Telangiectasia 28.46
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 28.4
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 28.4
Next Generation Sequencing of human SMA and healthy control Motor Neurons 28.14
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 28.08
Differentially expressed vascular development genes for iPSC-ECs from CDI 28.07
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 28.05
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 27.98
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 27.97
NR2F2 study 27.97
DIGIT regulates endoderm differentiation of human embryonic stem cells 27.74
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 27.61
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 27.61
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 27.45
High-Throughput Kinetic Analysis of Fractional Killing 27.37
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 27.32
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 27.32
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 27.31
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 27.3
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 27.22
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 27.22
Controlling for gene expression changes in transcription factor protein networks. 27.04
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 26.76
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 26.53
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 26.53
RNA sequencing analysis of human embryonic stem cells and axial progenitors 26.41
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 26.26
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 26.25
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 26.23
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 26.11
An acquired vulnerability of drug resistant melanoma with therapeutic potential 26.11
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 26.1
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 25.87
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 25.75
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 25.66
Role of CD133 molecule in WNT response and renal repair 25.66
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 25.55
Genome-wide functional assessment of enhancer activities in the human genome 25.42
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 25.39
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 25.31
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 25.31
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 25.27
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 25.23
Gene expression patterns define the hepatocyte-like cells derived by different strategies 25.23
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 25.08
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 25.01
SETBP1-WT and SETBP1-G870S epigenetic landscapes 25.01
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 25.0
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 24.9
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 24.87
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 24.81
Role of microRNAs in the interaction between Salmonella and the host cell 24.41
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 24.27
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 24.27
RNA Sequencing of three pairs of gastric cancer 24.23
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 24.19
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 23.77
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 23.67
The cohesin complex prevents Myc-induced replication stress 23.65
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 23.55
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 23.38
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 23.33
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 23.25
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 23.2
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 22.87
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 22.82
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 22.56
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 22.54
Postnatal lipids drive hepatocyte maturation 22.12
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 22.1
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 22.08
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 22.08
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 22.0
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 22.0
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 22.0
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 22.0
Identification of Atrial Fibrillation associated genes and functional non-coding variants 21.97
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 21.72
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 21.72
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 21.42
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 21.33
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 21.33
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 21.17
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 21.03
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 21.03
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 20.93
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 20.9
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 20.56
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 20.55
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 20.52
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 20.52
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 20.43
Transcriptome profiling of 5 human adenocarcinoma cell lines 20.43
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 20.41
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 20.37
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 20.34
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 20.2
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 20.2
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 20.08
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 19.9
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 19.64
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 19.34
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 19.09
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 18.91
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 18.66
EWS-Fli and LNC regulated genes in comparison to GFP samples 18.46
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 18.45
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 18.45
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 18.41
Comparing gene expression in iPSC derived RPE from control and AMD donors 17.81
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 17.65
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 17.65
Transcriptomic analysis of LSD1 17.6
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 17.49
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 17.42
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 17.42
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 17.41
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 17.22
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 17.19
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 16.81
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 16.74
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 16.6
Gene Expression Profiling of WT and KDM3A Knocked out Cell 16.6
RNA seq_PDX2_SHP099 16.54
Metastasis in triple-negative breast cancer 16.5
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 16.5
Genome wide miR-191 target profile determined by RIP and gene expression profiling 16.19
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 16.19
Gene expression profile of human placenta from T. Cruzi infected mothers 16.13
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 15.88
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 15.88
Zika virus infection reprograms global transcription of host cells to allow sustained infection 15.83
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 15.35
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 15.3
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 15.03
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 14.99
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 14.97
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 14.86
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 14.74
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 14.74
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 14.74
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 14.26
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 14.13
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 14.12
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 14.1
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 14.04
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 14.0
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 13.97
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 13.95
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 13.86
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 13.8
Functional astrocytes differentiated from hiPSCs 13.76
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 13.69
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 13.37
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 13.37
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 13.33
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 13.25
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 13.23
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 13.17
RNA-seq melanoma 13.17
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 13.14
Gene expression profiling of papillary thyroid cancer from central and invasive regions 13.03
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 13.02
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 13.01
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 12.95
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 12.95
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 12.64
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 12.44
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 12.32
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 12.31
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 12.31
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 12.14
Transcriptomic analysis of ERR alpha orphan nuclear receptor 12.08
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 11.9
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 11.82
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 11.61
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 11.47
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 11.47
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 11.47
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 11.47
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 11.24
Expression charcaterization of an internal protocol developed to differentiate RPE cells 11.19
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 11.04
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 11.04
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 10.77
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 10.77
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 10.77
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 10.77
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 10.76
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 10.46
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 10.39
RNA-seq analysis of gene expression patterns during hESC neural differentiation 10.38
hESC neural differentiation 10.38
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 10.36
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 10.33
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 10.27
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 10.27
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 10.09
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 9.97
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 9.85
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 9.85
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 9.73
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 9.73
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 9.68
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 9.65
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 9.54
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 9.44
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 9.35
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 9.07
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 9.07
Primate transcript and protein expression levels evolve under compensatory selection pressures 9.07
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 8.89
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 8.89
The comparison of high-throughput single-cell RNA-seq methods 8.85
Ribosome profiling upon inhibition of eIF4A 8.82
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 8.77
Gene expression profile of CRC-derived HILEC 8.68
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 8.65
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 8.59
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 8.17
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 7.9
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 7.79
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 7.75
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 7.34
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 7.34
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 7.31
Genome-wide discovery of human splicing branchpoints [RNAse] 7.19
CSL RNA-Seq on HKC and SCC cell lines 6.68
CSL 6.68
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 6.43
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 6.34
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 6.19
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 5.89
RNA-Seq of Breast and Ovarian Cancer Cell Lines 5.84
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 5.39
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 5.33
mRNA sequencing of oropharyngeal cancer cell lines 5.29
CHCHD2 gene KO effect in iPSC drived motor neurons 5.2
Deep RNA sequencing of the human placental transcriptome 5.11
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 4.99
Transcriptional responses of melanoma cells to BRAF inhibition 4.82
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 4.73
Bone marrow derived human B cells [normal proB] 4.69
RNA expression profiles comparing primary and omental ovarian carcinoma samples 4.63
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 4.62
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 4.58
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 4.58
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 4.29
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 4.23
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 4.08
Characterization of the Merkel cell carcinoma miRNome 3.95
Exploring ILF2 regulatory genes by next-generation sequencing 3.76
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 3.71
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 3.52
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 3.3
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 3.19
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 3.01
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 2.8
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 2.68
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 2.67
Transcriptome analysis reveals differential splicing events in IPF lung tissue 2.63
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 2.53
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 2.3
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 2.21
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 2.08
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.94
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.94
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 1.93
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.93
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.82
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 1.67
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.55
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 1.4
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 1.4
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 1.35
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 1.24
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 1.24
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 1.2
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 1.16
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 1.11
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 1.05
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 1.03
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.99
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 0.78
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.71
RNA-Seq in PWS iPSC-derived neurons 0.66
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.51
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.51
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.32
Fusion discovery in breast cancer cell line 0.25
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.2
Gene expression of thyroid cancer cell lines 0.15
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.14
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 0.13
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.1
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation